Enanta Pharmaceuticals (ENTA) FCF Margin Growth (1y) (2013 - 2026)
Enanta Pharmaceuticals (ENTA) FCF Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -89.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -1,183.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 869.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -7.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 811.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 769.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19,111.00 |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - | -16,424.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16,424.00 |
| Mar 31, 2026 | 10,799.00 |
| Dec 31, 2025 | 5,053.00 |
| Sep 30, 2025 | 14,702.00 |
| Jun 30, 2025 | 15,754.00 |
| Mar 31, 2025 | 3,157.00 |
| Dec 31, 2024 | 2,808.00 |
| Sep 30, 2024 | -4,025.00 |
| Jun 30, 2024 | 13,944.00 |
| Mar 31, 2024 | -9,479.00 |
| Dec 31, 2023 | 968.00 |
| Sep 30, 2023 | 1,084.00 |
| Jun 30, 2023 | -4,905.00 |
| Mar 31, 2023 | 5,513.00 |
| Dec 31, 2022 | -10,297.00 |
| Sep 30, 2022 | 428.00 |
| Jun 30, 2022 | -1,821.00 |
| Mar 31, 2022 | -11,822.00 |
| Dec 31, 2021 | -67.00 |
| Sep 30, 2021 | -2,501.00 |